{"id":"https://openalex.org/W7225415779","doi":"https://doi.org/10.1111/jdv.70838","title":"Increased incidence and healthcare burden of bullous pemphigoid: A population\u2010based cohort study","display_name":"Increased incidence and healthcare burden of bullous pemphigoid: A population\u2010based cohort study","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225415779","doi":"https://doi.org/10.1111/jdv.70838","pmid":"https://pubmed.ncbi.nlm.nih.gov/42992638"},"language":"en","primary_location":{"id":"doi:10.1111/jdv.70838","doi":"https://doi.org/10.1111/jdv.70838","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.70838","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70838","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70838","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084259122","display_name":"Anna Carina Meyer","orcid":"https://orcid.org/0000-0003-2749-7179","observed_orcids":["https://orcid.org/0000-0003-2749-7179"]},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Anna C. Meyer","raw_affiliation_strings":["Sanofi\u2010Aventis Deutschland GmbH  Berlin Germany"],"raw_orcid":"https://orcid.org/0000-0003-2749-7179","affiliations":[{"raw_affiliation_string":"Sanofi\u2010Aventis Deutschland GmbH  Berlin Germany","institution_ids":["https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110770840","display_name":"Inka Albrecht","orcid":"https://orcid.org/0009-0006-6384-662X","observed_orcids":["https://orcid.org/0009-0006-6384-662X"]},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Inka Albrecht","raw_affiliation_strings":["Sanofi\u2010Aventis Deutschland GmbH  Berlin Germany"],"raw_orcid":"https://orcid.org/0009-0006-6384-662X","affiliations":[{"raw_affiliation_string":"Sanofi\u2010Aventis Deutschland GmbH  Berlin Germany","institution_ids":["https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050709605","display_name":"Lena Hasemann","orcid":"https://orcid.org/0000-0001-5609-0971","observed_orcids":["https://orcid.org/0000-0001-5609-0971"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lena Hasemann","raw_affiliation_strings":["Vandage GmbH  Bielefeld Germany"],"raw_orcid":"https://orcid.org/0000-0001-5609-0971","affiliations":[{"raw_affiliation_string":"Vandage GmbH  Bielefeld Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049541619","display_name":"Jana Diekmannshemke","orcid":"https://orcid.org/0009-0008-8812-3123","observed_orcids":["https://orcid.org/0009-0008-8812-3123"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jana Diekmannshemke","raw_affiliation_strings":["Vandage GmbH  Bielefeld Germany"],"raw_orcid":"https://orcid.org/0009-0008-8812-3123","affiliations":[{"raw_affiliation_string":"Vandage GmbH  Bielefeld Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016189991","display_name":"Oliver Damm","orcid":"https://orcid.org/0000-0003-0261-3655","observed_orcids":["https://orcid.org/0000-0003-0261-3655"]},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Oliver Damm","raw_affiliation_strings":["Sanofi\u2010Aventis Deutschland GmbH  Berlin Germany"],"raw_orcid":"https://orcid.org/0000-0003-0261-3655","affiliations":[{"raw_affiliation_string":"Sanofi\u2010Aventis Deutschland GmbH  Berlin Germany","institution_ids":["https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066223532","display_name":"Daniel Gensorowsky","orcid":"https://orcid.org/0000-0001-9326-2963","observed_orcids":["https://orcid.org/0000-0001-9326-2963"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Gensorowsky","raw_affiliation_strings":["Vandage GmbH  Bielefeld Germany"],"raw_orcid":"https://orcid.org/0000-0001-9326-2963","affiliations":[{"raw_affiliation_string":"Vandage GmbH  Bielefeld Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088591482","display_name":"Julian Witte","orcid":"https://orcid.org/0000-0003-2075-323X","observed_orcids":["https://orcid.org/0000-0003-2075-323X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Julian Witte","raw_affiliation_strings":["Vandage GmbH  Bielefeld Germany"],"raw_orcid":"https://orcid.org/0000-0003-2075-323X","affiliations":[{"raw_affiliation_string":"Vandage GmbH  Bielefeld Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065071235","display_name":"Sven Quist","orcid":"https://orcid.org/0000-0002-9548-7813","observed_orcids":["https://orcid.org/0000-0002-9548-7813"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sven R. Quist","raw_affiliation_strings":["Clinic of Dermatology Helix Medical Excellence Center Mainz  Mainz Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic of Dermatology Helix Medical Excellence Center Mainz  Mainz Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074895170","display_name":"Ulrike Raap","orcid":"https://orcid.org/0000-0002-9573-4714","observed_orcids":["https://orcid.org/0000-0002-9573-4714"]},"institutions":[{"id":"https://openalex.org/I129877168","display_name":"Carl von Ossietzky Universit\u00e4t Oldenburg","ror":"https://ror.org/033n9gh91","country_code":"DE","type":"education","lineage":["https://openalex.org/I129877168"]},{"id":"https://openalex.org/I4210108766","display_name":"Klinikum Oldenburg","ror":"https://ror.org/01t0n2c80","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210108766"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ulrike Raap","raw_affiliation_strings":["Department of Dermatology and Allergy Klinikum Oldenburg  Oldenburg Germany","Division of Experimental Allergy and Immunodermatology Carl von Ossietzky University of Oldenburg  Oldenburg Germany"],"raw_orcid":"https://orcid.org/0000-0002-9573-4714","affiliations":[{"raw_affiliation_string":"Department of Dermatology and Allergy Klinikum Oldenburg  Oldenburg Germany","institution_ids":["https://openalex.org/I4210108766"]},{"raw_affiliation_string":"Division of Experimental Allergy and Immunodermatology Carl von Ossietzky University of Oldenburg  Oldenburg Germany","institution_ids":["https://openalex.org/I129877168"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067198663","display_name":"Enno Schmidt","orcid":"https://orcid.org/0000-0002-1206-8913","observed_orcids":["https://orcid.org/0000-0002-1206-8913","https://orcid.org/0000-0002-6119-1870"]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]},{"id":"https://openalex.org/I9341345","display_name":"University of L\u00fcbeck","ror":"https://ror.org/00t3r8h32","country_code":"DE","type":"education","lineage":["https://openalex.org/I9341345"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Enno Schmidt","raw_affiliation_strings":["Department of Dermatology University Hospital Schleswig\u2010Holstein  Kiel Germany","L\u00fcbecker Institute of Experimental Dermatology University of L\u00fcbeck  L\u00fcbeck Germany"],"raw_orcid":"https://orcid.org/0000-0002-1206-8913","affiliations":[{"raw_affiliation_string":"Department of Dermatology University Hospital Schleswig\u2010Holstein  Kiel Germany","institution_ids":["https://openalex.org/I4210112713"]},{"raw_affiliation_string":"L\u00fcbecker Institute of Experimental Dermatology University of L\u00fcbeck  L\u00fcbeck Germany","institution_ids":["https://openalex.org/I9341345"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5088591482"],"corresponding_institution_ids":[],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":{"value":5450,"currency":"USD","value_usd":5450},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11650","display_name":"Skin and Cellular Biology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bullous-pemphigoid","display_name":"bullous pemphigoid","score":1.0},{"id":"https://openalex.org/keywords/autoimmune-blistering-disease","display_name":"autoimmune blistering disease","score":0.9160000085830688},{"id":"https://openalex.org/keywords/incidence","display_name":"incidence","score":0.6669999957084656},{"id":"https://openalex.org/keywords/prevalence","display_name":"prevalence","score":0.9539999961853027},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.6690000295639038},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.9879999756813049},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.9269999861717224},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.8830000162124634},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.8659999966621399},{"id":"https://openalex.org/keywords/steroid-sparing-therapy","display_name":"steroid-sparing therapy","score":0.7929999828338623},{"id":"https://openalex.org/keywords/doxycycline","display_name":"doxycycline","score":0.7170000076293945},{"id":"https://openalex.org/keywords/dapsone","display_name":"dapsone","score":0.9929999709129333},{"id":"https://openalex.org/keywords/azathioprine","display_name":"azathioprine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.7310000061988831},{"id":"https://openalex.org/keywords/germany","display_name":"Germany","score":0.652999997138977},{"id":"https://openalex.org/keywords/statutory-health-insurance-claims","display_name":"statutory health insurance claims","score":0.7360000014305115},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.5299999713897705},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.656000018119812},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.4869999885559082},{"id":"https://openalex.org/keywords/physician-visits","display_name":"physician visits","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9728000164031982},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.656000018119812},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6557000279426575},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.5512999892234802},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4968000054359436},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4593000113964081},{"id":"https://openalex.org/C2780664029","wikidata":"https://www.wikidata.org/wiki/Q5282120","display_name":"Disease burden","level":3,"score":0.429500013589859},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4212999939918518},{"id":"https://openalex.org/C167704817","wikidata":"https://www.wikidata.org/wiki/Q7295548","display_name":"Rate ratio","level":3,"score":0.40149998664855957},{"id":"https://openalex.org/C3019063607","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Charlson comorbidity index","level":3,"score":0.38679999113082886},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.3582000136375427},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.35249999165534973},{"id":"https://openalex.org/C179755657","wikidata":"https://www.wikidata.org/wiki/Q58702","display_name":"Mortality rate","level":2,"score":0.3513000011444092},{"id":"https://openalex.org/C2776760755","wikidata":"https://www.wikidata.org/wiki/Q18939","display_name":"Azathioprine","level":3,"score":0.34119999408721924},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3181000053882599},{"id":"https://openalex.org/C3020448403","wikidata":"https://www.wikidata.org/wiki/Q5282120","display_name":"Burden of disease","level":3,"score":0.3165000081062317},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.31450000405311584},{"id":"https://openalex.org/C133925201","wikidata":"https://www.wikidata.org/wiki/Q188419","display_name":"Life expectancy","level":3,"score":0.31349998712539673},{"id":"https://openalex.org/C2779252107","wikidata":"https://www.wikidata.org/wiki/Q1004647","display_name":"Bullous pemphigoid","level":3,"score":0.303600013256073},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.301800012588501},{"id":"https://openalex.org/C2776738588","wikidata":"https://www.wikidata.org/wiki/Q1567856","display_name":"Pharmacoeconomics","level":2,"score":0.2978000044822693},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.2962000072002411},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2946000099182129},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.28790000081062317},{"id":"https://openalex.org/C6964187","wikidata":"https://www.wikidata.org/wiki/Q659256","display_name":"Indirect costs","level":2,"score":0.27549999952316284},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.27390000224113464},{"id":"https://openalex.org/C2779195980","wikidata":"https://www.wikidata.org/wiki/Q5691206","display_name":"Healthcare Cost and Utilization Project","level":3,"score":0.2709999978542328},{"id":"https://openalex.org/C2780877353","wikidata":"https://www.wikidata.org/wiki/Q2518253","display_name":"Health services research","level":3,"score":0.26660001277923584},{"id":"https://openalex.org/C182299520","wikidata":"https://www.wikidata.org/wiki/Q1289588","display_name":"Total cost","level":2,"score":0.2660999894142151},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26409998536109924},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.2565000057220459},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.2538999915122986},{"id":"https://openalex.org/C2778049256","wikidata":"https://www.wikidata.org/wiki/Q55627","display_name":"Disability-adjusted life year","level":4,"score":0.25360000133514404},{"id":"https://openalex.org/C186079640","wikidata":"https://www.wikidata.org/wiki/Q719602","display_name":"Prevalence","level":3,"score":0.2517000138759613}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1111/jdv.70838","doi":"https://doi.org/10.1111/jdv.70838","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.70838","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70838","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},{"id":"pmid:42992638","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42992638","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology : JEADV","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/jdv.70838","doi":"https://doi.org/10.1111/jdv.70838","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.70838","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70838","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225415779.pdf","grobid_xml":"https://content.openalex.org/works/W7225415779.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1877946602","https://openalex.org/W1981248553","https://openalex.org/W2057780602","https://openalex.org/W2111620283","https://openalex.org/W2113309969","https://openalex.org/W2135033359","https://openalex.org/W2154769054","https://openalex.org/W2162560453","https://openalex.org/W2167905903","https://openalex.org/W2397464061","https://openalex.org/W2481199173","https://openalex.org/W2575603189","https://openalex.org/W2612492130","https://openalex.org/W2750641703","https://openalex.org/W2772643359","https://openalex.org/W2811056062","https://openalex.org/W2888301294","https://openalex.org/W3025913650","https://openalex.org/W3093342456","https://openalex.org/W3107816247","https://openalex.org/W3120644156","https://openalex.org/W3137470997","https://openalex.org/W3196365021","https://openalex.org/W3215508517","https://openalex.org/W4211003831","https://openalex.org/W4223627412","https://openalex.org/W4224011879","https://openalex.org/W4283722628","https://openalex.org/W4385898910","https://openalex.org/W4390043025","https://openalex.org/W4396774304","https://openalex.org/W4400246204","https://openalex.org/W4402581514","https://openalex.org/W4402648940","https://openalex.org/W4402903232","https://openalex.org/W4403818872","https://openalex.org/W4404204632","https://openalex.org/W4407796339"],"related_works":["https://openalex.org/W3010967672","https://openalex.org/W4401900369","https://openalex.org/W2089143852","https://openalex.org/W4412443062","https://openalex.org/W2122082757","https://openalex.org/W4407307097","https://openalex.org/W4412442581","https://openalex.org/W3196365021","https://openalex.org/W2750641703","https://openalex.org/W2460486510"],"abstract_inverted_index":{"BACKGROUND:":[0],"Bullous":[1],"pemphigoid":[2],"(BP)":[3],"is":[4],"the":[5,20,82,148,253,296],"most":[6],"common":[7],"autoimmune":[8],"blistering":[9],"disease":[10],"and":[11,19,32,48,78,107,116,129,145,185,217,226,233,245,285,300],"primarily":[12],"affects":[13],"older":[14],"adults.":[15],"As":[16],"societies":[17],"age":[18],"burden":[21,34,50,175],"of":[22,235],"age-related":[23],"diseases":[24],"increases,":[25],"data":[26],"on":[27,292],"BP":[28,42,132,169,207,259,271],"epidemiology,":[29,43],"treatment":[30,289],"patterns":[31],"healthcare":[33,46,102,105,250,275,286],"in":[35,51,57,231],"Germany":[36],"remain":[37],"limited.":[38],"OBJECTIVES:":[39],"To":[40],"assess":[41],"clinical":[44],"outcomes,":[45],"utilization":[47,203],"economic":[49],"adults":[52],"aged":[53,154],"\u2265":[54,155],"18":[55],"years":[56],"Germany.":[58],"METHODS:":[59],"We":[60],"analysed":[61,119],"anonymized":[62],"statutory":[63],"health":[64],"insurance":[65],"claims":[66],"from":[67,135,161],"6.8":[68],"million":[69,167],"insured":[70],"individuals":[71,142,153],"(2010-2023).":[72],"Annual":[73,158],"cross-sectional":[74],"analyses":[75],"estimated":[76],"prevalence":[77,133],"incidence,":[79],"extrapolated":[80],"to":[81,112,137,163,267],"national":[83],"population.":[84],"In":[85],"a":[86,172,273,279],"matched":[87,177],"incident":[88],"cohort":[89],"(BP,":[90],"n":[91,95],"=":[92,96],"2004;":[93],"controls,":[94,264],"9950),":[97],"we":[98],"evaluated":[99],"comorbidity,":[100],"mortality,":[101],"resource":[103],"utilization,":[104],"costs":[106,117,251],"pharmacologic":[108],"management":[109],"over":[110],"up":[111],"2":[113],"years.":[114,157],"Mortality":[115],"were":[118,229,256],"using":[120],"regression":[121],"models":[122],"adjusted":[123,193],"for":[124,258,263,298],"age,":[125],"sex,":[126],"calendar":[127],"year,":[128],"comorbidity.":[130],"RESULTS:":[131],"tripled":[134],"0.05":[136],"0.14":[138],"cases":[139,165],"per":[140,166,215,223],"1000":[141],"between":[143],"2010":[144],"2023,":[146],"with":[147],"steepest":[149],"increase":[150],"observed":[151],"among":[152,206],"80":[156],"incidence":[159,194],"ranged":[160],"34":[162],"63":[164],"inhabitants.":[168],"patients":[170,260],"exhibited":[171],"higher":[173,205],"comorbidity":[174,281],"than":[176],"controls":[178],"(mean":[179],"Elixhauser":[180],"index":[181],"5.0":[182],"vs.":[183,191,213,221],"3.8)":[184],"increased":[186,283],"mortality":[187,284],"(1-year":[188],"mortality:":[189],"18.8%":[190],"6.0%;":[192],"rate":[195],"ratio":[196],"(IRR)":[197],"3.09,":[198],"95%":[199],"CI:":[200],"2.71-3.52).":[201],"Healthcare":[202],"was":[204],"patients,":[208,236],"including":[209],"physician":[210],"contacts":[211],"(38":[212],"22":[214],"year)":[216],"hospital":[218],"admissions":[219],"(3.3":[220],"0.7":[222],"year).":[224],"Topical":[225],"systemic":[227,293],"corticosteroids":[228],"prescribed":[230],"75%":[232],"72%":[234],"respectively;":[237],"additional":[238],"therapies":[239],"included":[240],"doxycycline":[241],"(19.7%),":[242],"dapsone":[243],"(15.0%)":[244],"azathioprine":[246],"(14.8%).":[247],"Mean":[248],"total":[249],"during":[252],"first":[254],"year":[255],"\u20ac20,881":[257],"versus":[261],"\u20ac5586":[262],"mainly":[265],"attributable":[266],"inpatient":[268],"care.":[269],"CONCLUSIONS:":[270],"represents":[272],"growing":[274],"challenge":[276],"characterized":[277],"by":[278],"high":[280],"burden,":[282],"costs.":[287],"Current":[288],"remains":[290],"reliant":[291],"corticosteroids,":[294],"underscoring":[295],"need":[297],"safe":[299],"effective":[301],"steroid-sparing":[302],"therapies.":[303]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-07T00:00:00"}